SALLY BODENSTEINER: Open Payments
NPI 1851580823 · VINCENNES, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,006 in 53 payments from 22 companies in 2025. Trend: 2023 $472 · 2024 $448 · 2025 $1,006
Food & beverage: $1,006
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $166 |
| Indivior Inc. | 9 | $142 |
| Axsome Therapeutics, Inc. | 4 | $113 |
| AstraZeneca Pharmaceuticals LP | 6 | $106 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $63 |
| ABBVIE INC. | 3 | $53 |
| Lilly USA, LLC | 3 | $51 |
| Vanda Pharmaceuticals Inc. | 1 | $39 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
Products named: CAPLYTA, SUBLOCADE, Auvelity, Kerendia, BREZTRI, FANAPT, JARDIANCE, QULIPTA.
Industry payments across IN — which companies pay providers there.
